phosphorus has been researched along with 9,10-dimethyl-1,2-benzanthracene in 6 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 6,010 | 10 | 772 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bojsen, J; Møoller, U | 1 |
| Croisy, A; Guerquin-Kern, JL; Leteurtre, F; Lhoste, JM | 1 |
| Koyama, H; Miyauchi, K; Noguchi, S; Tahara, H | 1 |
| Askenazy, N; Kaplan, O; Knubovets, T; Kushnir, T; Navon, G | 1 |
| Bélanger, A; Labrie, C; Labrie, F; Luo, S | 1 |
| Bélanger, A; Labrie, C; Labrie, F; Luo, S; Sourla, A | 1 |
1 trial(s) available for phosphorus and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaline Phosphatase; Animals; Body Weight; Bone Density; Calcium; Carcinogens; Cholesterol; Dehydroepiandrosterone; Dihydrotestosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Female; Femur; Lipids; Lumbar Vertebrae; Mammary Neoplasms, Experimental; Phosphorus; Rats; Rats, Sprague-Dawley; Testosterone; Triglycerides | 1997 |
5 other study(ies) available for phosphorus and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Circadian variations in 32P uptake of DMBA-induced mammary tumour and Walker carcinosarcoma in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Temperature; Carcinoma 256, Walker; Circadian Rhythm; Darkness; Female; Mammary Neoplasms, Experimental; Phosphorus; Rats; Skin | 1976 |
pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; beta-Alanine; Fibrosarcoma; Fluorine; Fluorouracil; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Phosphorus; Rats; Rats, Inbred Strains; Urea | 1991 |
Influence of 1 alpha,25-dihydroxyvitamin D3 on the development and steroid hormone receptor contents of DMBA-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Calcitriol; Calcium; Female; Mammary Neoplasms, Experimental; Ovary; Phosphorus; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1989 |
Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Carcinogens; Cricetinae; Deoxyglucose; Humans; Indazoles; Magnetic Resonance Spectroscopy; Male; Mesocricetus; Neoplasm Transplantation; Pancreatic Neoplasms; Phosphorus; Protons; Rats; Rats, Sprague-Dawley; Sodium; Tumor Cells, Cultured | 1997 |
Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaline Phosphatase; Animals; Benzopyrans; Bone Density; Calcium; Carcinogens; Cell Transformation, Neoplastic; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Female; Genitalia, Female; Lipids; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Phosphorus; Prolactin; Propionates; Random Allocation; Rats; Rats, Sprague-Dawley | 1997 |